Most US neurologists prescribing multiple sclerosis drugs receive pharma industry payments Nearly 80% of US neurologists prescribing drugs for multiple sclerosis (MS) received at least one pharma industry payment, with higher volume prescribers more likely to be beneficiaries, finds a 5 year analysis of Medicare database payments, published in the open access journal BMJ Open.
https://www.news-medical.net/n....ews/20250827/Most-US